Investing
The acquisition will allow Tempus to expand its technical team and create a stronger presence in digital pathology.
British Growth Fund’s exit marks one of the largest for a UK medtech company and the most profitable return in the firm’s history.
The company plans to expand partnerships with health plans and employers to provide more individuals with digital twin technology designed to improve metabolic health.
After securing an additional $5 million in Series B funding, Naluri looks to enter the Philippines and Vietnam.
The company will use the funds to expand EHR and PBM integrations and partner with digital health and other companies to expand medication access.
CredAlliance aims to eliminate duplication of the credentialing process for providers.
The company will use the funds to expand its technology offerings and nationwide partnerships.
The company will use the funds to open a new headquarters in the Bay Area, scale its reach and platform, and expand its workforce.
The company will use the newly garnered funds to scale its Medical-Grade AI offering.
Also, Neurophet will tap into Roche's data to further improve its brain scan analysis AI.